Author(s)

Zuo Tie, Li Xinlei, Ren Yang

Corresponding Author

Zuo Tie

ABSTRACT

The incidence of non-small cell lung cancer accounts for 86% of all lung cancer patients. It is a malignant disease that originates from lung cancer cells. In the past few decades, treatment for non-small cell lung cancer has been achieved great results. However, the current treatment efficiency of non-small cell lung cancer is still far below the expectation. The occurrence of non-small cell lung cancer is closely related to the body's immune function. Regulating T/B lymphocyte is an immune system. To regulate the function of cell subsets, this paper combines the study of regulatory T/B lymphocytes in the construction of non-small cell lung cancer immune mechanisms.

KEYWORDS

Regulatory T/B lymphocytes, non-small cell lung cancer, immune mechanism